Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: OlaszországFázis nélkül

A ProspeCtive mUlticenteR Investigation on RENzar Stent Safety and Efficacy in the Treatment of Patients With Femoro-popliteal Disease in Tuscany (CURRENT Registry)

A legfontosabb adatok

Ki végzi
Azienda Ospedaliera Universitaria Senese
Hol
Siena (Olaszország)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
100 fő, tervezett
Kezdés
2022. dec. 1.
Várható befejezés
2026. dec. 1.
A vizsgálat típusa
Megfigyeléses
A vizsgált kezelések
  • Endovascular implantation of Renzan Stent
A regiszteradat frissítve
2023. július 20.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with narrowed or blocked arteries in the thigh or behind the knee (femoro-popliteal disease). They will be treated with the Renzan stent.

Életkor
18 years or older
Nem
All sexes
A betegség stádiuma
Rutherford-Becker category 2 to 5, with a resting ankle-brachial index (ABI) of 0.9 or less. The common femoral, superficial femoral and/or popliteal artery must be more than 50% narrowed or fully blocked. The artery width must be between 4.0 mm and 8.0 mm. New narrowings and re-narrowings, also inside an old stent, can be treated. At least one open lower-leg artery below the narrowing is needed.
Korábbi kezelés
People cannot join if they had a heart artery procedure less than 90 days before, or one is planned within 30 days after. Clot-dissolving treatment of the target artery within 72 hours before is not allowed.

A részvétel fő kizáró okai

  • Rutherford-Becker category 6 (tissue loss)
  • Allergy or intolerance to nitinol (nickel titanium), or unable to take antiplatelet or blood-thinning drugs
  • Dialysis within the previous 30 days, or stroke within the previous 90 days
  • Pregnant or able to become pregnant
  • Life expectancy of less than 1 year

A regiszter feltételei, szó szerint

Mind a 29 feltétel megnézéseKevesebb

Ki vehet részt

  • Age ≥18 years
  • Subject must provide written informed consent prior to the treatment of the target lesion
  • Subject must be willing to comply with the specified follow-up evaluation schedule
  • Subject with Rutherford-Becker clinical classification category 2 to 5, with a resting ankle-brachial index (ABI) ≤ 0.9
  • Common femoral, superficial femoral and/or popliteal artery lesion with > 50% stenosis or total occlusion
  • Stenotic or occluded lesion(s) within the same vessel with no length limits
  • De novo or restenotic/occluded lesion(s) including in-stent restenosis, with reference vessel diameter (RVD) ≥ 4.0 mm and ≤ 8.0 mm by visual assessment and no length limits
  • Multiple RENZAN stents could be deployed with a mandatory overlap of 0.5-1 cm
  • A patent inflow artery free from the significant lesion (≥50% stenosis) as confirmed by angiography (treatment of target lesion acceptable after successful treatment of ipsilateral iliac lesions); Successful ipsilateral iliac artery treatment is defined as the attainment of residual diameter stenosis ≤30%, either with PTA or stenting
  • The target lesion(s) can be successfully crossed with a guide wire and dilated up to 1:1 to the proposed stent to be implanted (as per the operator's assessment)
  • At least one patent native outflow artery (anterior or posterior tibial or peroneal), free from significant (≥50%) stenosis (as confirmed by angiography), that has not previously been revascularized. The remaining outflow arteries requiring treatment during the same procedure may be treated

Ki nem vehet részt

  • Use of drug-eluting balloon or stent
  • Concomitant use of different stent platforms
  • Subject with coronary intervention performed less than 90 days prior to or planned within 30 days after the treatment of the target lesion
  • Any contraindication or known unresponsiveness to dual antiplatelet therapy (DAPT) or anticoagulation therapy
  • Presence of acute thrombus prior to crossing the lesion
  • Thrombolysis of the target vessel within 72 hours prior to the index procedure
  • Thrombophlebitis or deep venous thrombus, within the previous 30 days
  • Subject receiving dialysis within the previous 30 days
  • Stroke within the previous 90 days
  • Known allergies or intolerance to nitinol (nickel titanium)
  • Subject has Rutherford-Becker classification category 6
  • Treatment of lesions requiring the use of adjunctive debulking devices
  • Inadequate vessel preparation not achieving a diameter of 1:1 to the stent to be implanted (with ≤20% residual stenosis, as per operator's assessment)
  • Any significant vessel tortuosity or other parameters prohibiting access to the lesion and/or preventing the stent delivery
  • Subject is pregnant or of childbearing potential
  • Subject has a life expectancy of less than 1 year
  • Subject is participating in an investigational study that has not reached the primary endpoint at the time of study screening
  • Only one patent outflow artery, with significant stenosis (≥50%) (as confirmed by angiography)

Helyszínek itt: Olaszország

  • University of SienaSiena, OlaszországContact: Edoardo Pasqui, MDRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

CURRENT Registry is a physician-initiated prospective, multicenter, post-market, single-arm study with a plan to include approximately 100 patients eligible to be treated with RenzanTM Peripheral Stent System.

A vizsgálat csoportja

  • LEAD patients undergoing endovascular treatment with implantation of Renzan stent

    Kezelés: Endovascular implantation of Renzan Stent

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2023. július 20.